Sargent Bickham Lagudis’s MARTEK BIOSCIENCES CORP MATK Stock Holding History

Sargent Bickham Lagudis’s Portfolio MATK Stock Details MATK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,930	Closed	-$133K	–	817
2016 Q2	$133K	Hold	3,930	–	–	0.02%	241
2016 Q1	$133K	Buy	+3,930	New	+$133K	0.02%	248

Sargent Bickham Lagudis's MATK Position: Q3 2016 in Review

Sargent Bickham Lagudis sold out of MARTEK BIOSCIENCES CORP (MATK) in Q3 2016, closing a stake of 3,930 shares — an estimated $133K sold.

Sargent Bickham Lagudis first reported a position in MATK in Q1 2016 and held it in 2 quarters. The position peaked at $133K in Q2 2016. 0 funds tracked by Wall St. Rank hold MATK as of Q3 2016.

Sargent Bickham Lagudis reported no remaining MARTEK BIOSCIENCES CORP position as of Q3 2016 after selling out during the quarter.
Sargent Bickham Lagudis sold 3,930 MARTEK BIOSCIENCES CORP shares in Q3 2016, an estimated $133K.
Sargent Bickham Lagudis first reported a position in MARTEK BIOSCIENCES CORP in Q1 2016 and held it in 2 quarters.
Sargent Bickham Lagudis's MARTEK BIOSCIENCES CORP position peaked at $133K in Q2 2016.
0 funds tracked by Wall St. Rank held MARTEK BIOSCIENCES CORP as of Q3 2016.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2016, filed 13 Sep 2021.